Pravastatin

Generic Name
Pravastatin
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C23H36O7
CAS Number
81093-37-0
Unique Ingredient Identifier
KXO2KT9N0G
Background

Pravastatin is the 6-alpha-hydroxy acid form of mevastatin. Pravastatin was firstly approved in 1991 becoming the second available statin in the United States. It was the first statin administered as the active form and not as a prodrug. This drug was developed by Sankyo Co. Ltd.; however, the first approved pravastatin product was developed by Bristol Myers...

Indication

Pravastatin is indicated for primary prevention of coronary events hypercholesterolemic patients without clinical evidence of coronary heart disease. Its use includes the reduction of risk on myocardial infarction, undergoing myocardial revascularization procedures and cardiovascular mortality.
...

Associated Conditions
Acute Coronary Events, Cardiovascular Outcomes, Coronary Artery Atherosclerosis, Death, Dysbetalipoproteinemia, Heterozygous Familial Hypercholesterolemia (HeFH), High Cholesterol, Hyperlipidemias, Mixed Dyslipidemias, Myocardial Infarction, Myocardial Revascularization, Secondary prevention cardiovascular event, Stroke, Sudden Cardiac Death, Transient Ischemic Attack, Elevation of serum triglyceride levels
Associated Therapies
-
Clinical Trials
Related News

Effect of Statin Use on Aldosterone Secretion

First Posted Date
2016-08-18
Last Posted Date
2022-09-29
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
103
Registration Number
NCT02871687
Locations
🇺🇸

Brigham and Women's Hospital- 221 Longwood Avenue, Boston, Massachusetts, United States

High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV

First Posted Date
2016-07-22
Last Posted Date
2022-10-18
Lead Sponsor
Matthew Feinstein
Target Recruit Count
10
Registration Number
NCT02841774
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Effect of Pravastatin in the Subjects With Prediabetes or Early Diabetes

First Posted Date
2016-04-28
Last Posted Date
2018-09-13
Lead Sponsor
Samsung Medical Center
Target Recruit Count
44
Registration Number
NCT02754739
Locations
🇰🇷

Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of

Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential

Phase 1
Completed
Conditions
Breast Cancer
Interventions
Drug: GDC-0810
Drug: Pravastatin
First Posted Date
2015-12-04
Last Posted Date
2016-11-02
Lead Sponsor
Genentech, Inc.
Target Recruit Count
15
Registration Number
NCT02621957

A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males

First Posted Date
2015-09-11
Last Posted Date
2016-05-03
Lead Sponsor
Complexa, Inc.
Target Recruit Count
10
Registration Number
NCT02547402
Locations
🇺🇸

Jasper Clinical Research & Development, Inc., Kalamazoo, Michigan, United States

High Potency Statins and Acute Kidney Injury

First Posted Date
2015-08-07
Last Posted Date
2016-03-14
Lead Sponsor
Canadian Network for Observational Drug Effect Studies, CNODES
Target Recruit Count
2067639
Registration Number
NCT02518516
Locations
🇨🇦

Dept. of Anesthesiology, Pharmacology & Therapeutics (APT), University of British Columbia, Vancouver, British Columbia, Canada

High Potency Statins and the Risk of Diabetes

First Posted Date
2015-08-07
Last Posted Date
2016-03-14
Lead Sponsor
Canadian Network for Observational Drug Effect Studies, CNODES
Target Recruit Count
136966
Registration Number
NCT02518503

Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children

Phase 1
Terminated
Conditions
Leukemia
Interventions
Drug: Bortezomib
Drug: Pravastatin
First Posted Date
2015-06-29
Last Posted Date
2023-03-15
Lead Sponsor
Reuven Schore
Target Recruit Count
10
Registration Number
NCT02484261
Locations
🇺🇸

Children's National Medical Center, Washington, District of Columbia, United States

Cilostazol-Simvastatin Drug Interaction Study

First Posted Date
2015-04-30
Last Posted Date
2015-05-01
Lead Sponsor
Ajou University School of Medicine
Target Recruit Count
20
Registration Number
NCT02431013
Locations
🇰🇷

Ajou University Medical Center, Suwon, Gyeonggi, Korea, Republic of

Statin Distribution

Phase 1
Completed
Conditions
Drug Distribution
Interventions
Drug: Pravastatin
Drug: Simvastatin
First Posted Date
2015-02-11
Last Posted Date
2017-07-19
Lead Sponsor
Children's Mercy Hospital Kansas City
Target Recruit Count
32
Registration Number
NCT02360826
Locations
🇺🇸

Children's Mercy Hospital, Kansas City, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy